Literature DB >> 32548167

Myxofibrosarcoma of the scalp with difficult preoperative diagnosis: A case report and review of the literature.

Xiao-Ting Ke1, Xiong-Feng Yu1, Ji-Yang Liu1, Fang Huang1, Mei-Gui Chen1, Qing-Quan Lai2.   

Abstract

BACKGROUND: A myxofibrosarcoma (MFS) is a malignant fibroblastic tumor that tends to occur in the lower and upper extremities. The reported incidence of head and neck MFSs is extremely rare. We report a 46-year-old male with "a neoplasm in the scalp" who was hospitalized and diagnosed with an MFS (highly malignant with massive necrotic lesions) based on histologic and immunohistochemistry evaluations. The magnetic resonance imaging manifestations did not demonstrate the "tail sign" mentioned in several studies, which resulted in a great challenge to establish an imaging diagnosis. The treatment plan is closely associated with the anatomic location and histologic grade, and more importantly, aggressive surgery and adjuvant radiotherapy may be helpful. Hence, we report the case and share some valuable information about the disease. CASE
SUMMARY: A 46-year-old male with "a neoplasm in the scalp for 6 mo" was hospitalized. Initially, the tumor was about the size of a soybean, without algesia or ulceration. The patient ignored the growth, did not seek treatment, and thus, did not receive treatment. Recently, the tumor increased to the size of an egg; there was no bleeding or algesia. His family history was unremarkable. No abnormalities were found upon laboratory testing, including routine hematologic, biochemistry, and tumor markers. Computed tomography showed an ovoid mass (6.25 cm × 3.29 cm × 3.09 cm in size) in the left frontal scalp with low density intermingled with equidense strips in adjacent areas of the scalp. Magnetic resonance imaging revealed a lesion with an irregular surface and an approximate size of 3.55 cm × 6.34 cm in the left frontal region, with clear boundaries and visible separation. Adjacent areas of the skull were damaged and the dura mater was involved. Contrast enhancement showed an uneven enhancement pattern. Surgery was performed and postoperative adjuvant radiotherapy was administered to avoid recurrence or metastasis. The post-operative pathologic diagnosis confirmed an MFS. A repeat computed tomography scan showed no local recurrence or distant metastasis 19 mo post-operatively.
CONCLUSION: The case reported herein of MFS was demonstrated in an extremely rare location on the scalp and had atypical magnetic resonance imaging findings, which serves as a reminder to radiologists of the possibility of this diagnosis to assist in clinical treatment. Given the special anatomic location and the high malignant potential of this rare tumor, combined surgical and adjuvant radiotherapy should be considered to avoid local recurrence and distant metastasis. The significance of regular follow-up is strongly recommended to improve the long-term survival rate. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Magnetic resonance imaging; Malignant fibrous histiocytoma; Myxofibrosarcoma; Scalp; Treatment

Year:  2020        PMID: 32548167      PMCID: PMC7281033          DOI: 10.12998/wjcc.v8.i11.2350

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  35 in total

1.  Primary myxofibrosarcoma of the esophagus.

Authors:  Howard K Song; Joseph I Miller
Journal:  J Thorac Cardiovasc Surg       Date:  2002-07       Impact factor: 5.209

Review 2.  Adult paratesticular myxofibrosarcoma: report of a rare entity and review of the literature.

Authors:  Burak Ozkan; Mustafa Ozgüroğlu; Hamdi Ozkara; Haydar Durak; Zübeyr Talat
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Assessment of soft tissue tumours of the extremities with diffusion echoplanar MR imaging.

Authors:  A Razek; N Nada; M Ghaniem; S Elkhamary
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

4.  Prognostic factors and outcomes of patients with myxofibrosarcoma.

Authors:  G Petur Nielsen; John T Mullen; Nicole J Look Hong; Francis J Hornicek; Kevin A Raskin; Sam S Yoon; Jackie Szymonifka; Beow Yeap; Yen-Lin Chen; Thomas F DeLaney
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

Review 5.  Soft tissue tumors of the head and neck: imaging-based review of the WHO classification.

Authors:  Ahmed Abdel Razek; Benjamin Y Huang
Journal:  Radiographics       Date:  2011 Nov-Dec       Impact factor: 5.333

6.  Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging.

Authors:  Robert A Lefkowitz; Jonathan Landa; Sinchun Hwang; Emily C Zabor; Chaya S Moskowitz; Narasimhan P Agaram; David M Panicek
Journal:  Skeletal Radiol       Date:  2013-01-15       Impact factor: 2.199

Review 7.  Orbital Myxofibrosarcoma: Case Report and Review of Literature.

Authors:  Brandon C Clair; George Salloum; Bryant P Carruth; Thomas A Bersani; Robert H Hill
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 Nov/Dec       Impact factor: 1.746

Review 8.  Head and neck myxofibrosarcoma: a case report and review of the literature.

Authors:  Giovanni Dell'Aversana Orabona; Giorgio Iaconetta; Vincenzo Abbate; Pasquale Piombino; Antonio Romano; Fabio Maglitto; Giovanni Salzano; Luigi Califano
Journal:  J Med Case Rep       Date:  2014-12-29

9.  Myxofibrosarcoma of the maxillary sinus.

Authors:  Anni Wong; Richard Chan Woo Park; Neena M Mirani; Jean Anderson Eloy
Journal:  Allergy Rhinol (Providence)       Date:  2017-06-01

10.  Primary low grade myxofibrosarcoma of the liver with benign presentation but malignant outcome: a case report.

Authors:  Zigong Shao; Baoping Jiao; Juanhan Yu; Hao Liu
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

View more
  1 in total

Review 1.  Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.

Authors:  Silvia Vanni; Alessandro De Vita; Lorena Gurrieri; Valentina Fausti; Giacomo Miserocchi; Chiara Spadazzi; Chiara Liverani; Claudia Cocchi; Chiara Calabrese; Alberto Bongiovanni; Nada Riva; Laura Mercatali; Federica Pieri; Roberto Casadei; Enrico Lucarelli; Toni Ibrahim
Journal:  Ther Adv Med Oncol       Date:  2022-06-28       Impact factor: 5.485

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.